Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: Physicochemical characterisation and in vitro release

International Journal of Pharmaceutics

Volumn 411, Issue 1-2, 2011, Pages 69-77

  Rupenthal, Ilva D ^a   Green, Colin R ^a   Alany, Raid G ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Anionic polysaccharides; Contact angle; Gelling behaviour; In situ gelling systems; In vitro release; Ocular drug delivery

Indexed keywords

ALGINIC ACID; CALCIUM ION; CARRAGEENAN; CATION; CHITOSAN; GELLAN; GENULACTA L 100; HYDROXYPROPYLMETHYLCELLULOSE; K CARRAGEENAN; KELCOGEL F; KELTROL F; POTASSIUM ION; PROTASAN UP CL 213; UNCLASSIFIED DRUG; XANTHAN;

ARTICLE; CHEMICAL PARAMETERS; CONTACT ANGLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; EYE IRRITATION; FLOW KINETICS; HYDROPHILICITY; INTRAOCULAR DRUG ADMINISTRATION; LACRIMAL DUCT; PRIORITY JOURNAL; SHEAR STRESS; TEAR FILM; VISCOSITY;

ADMINISTRATION, OPHTHALMIC; ALGINATES; BIOLOGICAL AVAILABILITY; CARRAGEENAN; CHITOSAN; CORNEA; DRUG DELIVERY SYSTEMS; EXCIPIENTS; EYE; GELS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; OPHTHALMIC SOLUTIONS; PHYSICOCHEMICAL PHENOMENA; POLYMERS; POLYSACCHARIDES; POLYSACCHARIDES, BACTERIAL; RHEOLOGY; SOLUBILITY; TEARS; VISCOSITY;

EID: 79955959772     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.042     Document Type: Article

References (43)

1. Albasini, M., Ludwig, A., 1995. Evaluation of polysaccharides intended for ophthalmic use in ocular dosage forms. Farmaco 50, 633-642.
2. Balasubramaniam, J., Kant, S., Pandit, J.K., 2003. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 53, 251-261.
3. Balasubramaniam, J., Pandit, J.K., 2003. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv. 10, 185-191. (Pubitemid 36993370)
4. Bertram, U., Bodmeier, R., 2006. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur. J. Pharm. Sci. 27, 62-71.
5. Bromberg, L., Alakhov, V.Y., Hatton, T.A., 2006. Self-assembling Pluronic(R)-modified polycations in gene delivery. Curr. Opin. Colloid Interface Sci. 11, 217-223.
6. Ceulemans, J., Ludwig, A., 2002. Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques. Eur. J. Pharm. Biopharm. 54, 41-50.
7. Ceulemans, J., Vinckier, I., Ludwig, A., 2002. The use of xanthangumin an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. J. Pharm. Sci. 91, 1117-1127.
8. Davidson, R.L., 1980. Handbook of Water Soluble Gums and Resins. Kingsport Press, New York.
9. Deasy, P.B., Quigley, K.J., 1991. Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use. Int. J. Pharm. 73, 117-123.
10. Diebold, Y., Calonge, M., 2010. Applications of nanoparticles in ophthalmology. Prog. Retin. Eye Res. 29, 596-609.
11. El-Kamel, A.H., 2002. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm. 241, 47-55.
12. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., Thom, D., 1973. Biological interactions between polysaccharides and divalent cations: the egg-box model. FEBS Lett. 32, 195-198.
13. Gupta, H., Velpandian, T., Jain, S., 2010. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery. J. Drug Target. 18, 499-505.
14. Higuchi, T., 1961. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 50, 874-875.
15. Jarvinen, K., Jarvinen, T., Urtti, A., 1995. Ocular absorption following topical delivery. Adv. Drug Deliv. Rev. 16, 3-19.
16. Jarvinen, T., Jarvinen, K., 1996. Prodrugs for improved ocular drug delivery. Adv. Drug Deliv. Rev. 19, 203-224.
17. Jones, D.S., Woolfson, A.D., Djokic, J., Coulter, W.A., 1996. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res. 13, 1734-1738.
18. Kalam, M.A., Sultana, Y., Samad, A., Ali, A., Aqil, M., Sharma, M., Mishra, A.K., 2008. Gelrite-based in vitro gelation ophthalmic drug delivery system of gatifloxacin. J. Dispersion Sci. Technol. 29, 89-96.
19. Katchalsky, A., Cooper, R.E., Upadhyay, J., Wassermann, A., 1961. Counter-ion fixation in alginates. J. Chem. Soc., 5198-5204.
20. Kaur, I.P., Garg, A., Singla, A.K., Aggarwal, D., 2004. Vesicular systems in ocular drug delivery: an overview. Int. J. Pharm. 269, 1-14.
21. Kaur, I.P., Smitha, R., 2002. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 28, 353-369.
22. Krauland, A.H., Leitner, V.M., Bernkop-Schnurch, A., 2003. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J. Pharm. Sci. 92, 1234-1241.
23. Lee, V.H.L., Li, V.H.K., 1989. Prodrugs for improved ocular drug delivery. Adv. Drug Deliv. Rev. 3, 1-38.
24. Meisner, D., Mezei, M., 1995. Liposome ocular delivery systems. Adv. Drug Deliv. Rev. 16, 75-93.
25. Morris, E.R., Cutler, A.N., Ross-Murphy, S.B., Rees, D.A., Price, J., 1981. Concentration and shear rate dependence of viscosity in random coil polysaccharide solutions. Carbohydr. Polym. 1, 5-21.
26. Morris, E.R., Rees, D.A., Robinson, G., 1980. Cation-specific aggregation of carrageenan helices: domain model of polymer gel structure. J. Mol. Biol. 138, 349-362.
27. Nagarwal, R.C., Kant, S., Singh, P.N., Maiti, P., Pandit, J.K., 2009. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J. Control. Release 136, 2-13.
28. Nerurkar, J., Jun, H.W., Price, J.C., Park, M.O., 2005. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm. Biopharm. 61, 56-68.
29. Pandit, N.K., Wang, D., 1998. Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels. Int. J. Pharm. 167, 183-189.
30. Parker, A., Brigand, G., Miniou, C., Trespoey, A., Vallee, P., 1993. Rheology and fracture of mixed [iota]- and [kappa]-carrageenan gels: two-step gelation. Carbohydr. Polym. 20, 253-262.
31. Qi, H., Chen, W., Huang, C., Li, L., Chen, C., Li, W., Wu, C., 2007. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int. J. Pharm. 337, 178-187.
32. Ricci, E.J., Lunardi, L.O., Nanclares, D.M., Marchetti, J.M., 2005. Sustained release of lidocaine from poloxamer 407 gels. Int. J. Pharm. 288, 235-244.
33. Rozier, A., Mazuel, C., Grove, J., Plazonnet, B., 1989. Gelrite(R): a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 57, 163-168.
34. Saettone, M.F., Chetoni, P., Cerbai, R., Mazzanti, G., Braghiroli, L., 1996. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four beta-blockers, and in vitro/in vivo toxic activity. Int. J. Pharm. 142, 103-113.
35. Shedden, A.H., Laurence, J., Barrish, A., Olah, T.V., 2001. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily. Doc. Ophthalmol. 103, 73-79.
36. Sinko, P.J., Martin, A.N., 2006. Martin's Physical Pharmacy Pharmaceutical Sciences: Physical Chemical Principles in the Pharmaceutical Sciences, 5th ed. Lippincott Williams &Wilkins, Philadelphia.
37. Sultana, Y., Aqil, M., Ali, A., 2006a. Ion-activated, Gelrite®-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv. 13, 215-219.
38. Sultana, Y., Aqil, M., Ali, A., Zafar, S., 2006b. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm. Dev. Technol. 11, 313-319.
39. Thrimawithana, T.R., Young, S., Dunstan, D.E., Alany, R.G., 2010. Texture and rheological characterization of kappa and iota carrageenan in the presence of counter ions. Carbohydr. Polym. 82, 69-77.
40. Verschueren, E., Van Santvliet, L., Ludwig, A., 1996. Evaluation of various carrageenans as ophthalmic viscolysers. S.T.P. Pharma Sci. 6, 203-210.
41. Wei, G., Xu, H., Ding, P.T., Li, S.M., Zheng, J.M., 2002. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J. Control. Release 83, 65-74. (Pubitemid 35239815)
42. Zatz, J.L., Knapp, S., 1984. Viscosity of xanthan gum solutions at low shear rates. J. Pharm. Sci. 73, 468-471.
43. Zimmer, A., Kreuter, J., 1995. Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Deliv. Rev. 16, 61-73.